Characterization of ZC3H15 as a potential TRAF-2-interacting protein implicated in the NFκB pathway and overexpressed in AML

Strausberg RL, Feingold EA, Grouse LH, et al: Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci USA. 99:16899–16903. 2002. View Article : Google Scholar : PubMed/NCBI

Gregory RC, Lord KA, Panek LB, Gaines P, Dillon SB and Wojchowski DM: Subtraction cloning and initial characterization of novel epo-immediate response genes. Cytokine. 12:845–857. 2000. View Article : Google Scholar : PubMed/NCBI

Ishikawa K, Azuma S, Ikawa S, Semba K and Inoue J: Identification of DRG family regulatory proteins (DFRPs): specific regulation of DRG1 and DRG2. Genes Cells. 10:139–150. 2005. View Article : Google Scholar : PubMed/NCBI

Capalbo G, Muller-Kuller T, Dietrich U, Hoelzer D, Ottmann OG and Scheuring UJ: Inhibition of X4-tropic HIV type 1 replication by knockdown of the cellular protein LEREPO4. AIDS Res Hum Retroviruses. 26:1155–1161. 2010. View Article : Google Scholar : PubMed/NCBI

Scheuring UJ, Pfeifer H, Wassmann B, et al: Early minimal residual disease (MRD) analysis during treatment of Philadelphia chromosome/Bcr-Abl-positive acute lymphoblastic leukemia with the Abl-tyrosine kinase inhibitor imatinib (STI571). Blood. 101:85–90. 2003. View Article : Google Scholar

Hebestreit K, Gröttrup S, Emden D, et al: Leukemia gene atlas - a public platform for integrative exploration of genome-wide molecular data. PLoS One. 7:e391482012. View Article : Google Scholar : PubMed/NCBI

Haferlach T, Kohlmann A, Wieczorek L, et al: Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. J Clin Oncol. 28:2529–2537. 2010. View Article : Google Scholar

Verhaak RG, Wouters BJ, Erpelinck CA, et al: Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling. Haematologica. 94:131–134. 2009. View Article : Google Scholar : PubMed/NCBI

Inoue J, Ishida T, Tsukamoto N, et al: Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp Cell Res. 254:14–24. 2000. View Article : Google Scholar : PubMed/NCBI

Mahajan MA, Park ST and Sun XH: Association of a novel GTP binding protein, DRG, with TAL oncogenic proteins. Oncogene. 12:2343–2350. 1996.PubMed/NCBI

Leipe DD, Wolf YI, Koonin EV and Aravind L: Classification and evolution of P-loop GTPases and related ATPases. J Mol Biol. 317:41–72. 2002. View Article : Google Scholar : PubMed/NCBI

Bradley JR and Pober JS: Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene. 20:6482–6491. 2001. View Article : Google Scholar : PubMed/NCBI

Dempsey PW, Doyle SE, He JQ and Cheng G: The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev. 14:193–209. 2003. View Article : Google Scholar : PubMed/NCBI

Schulze-Luehrmann J and Ghosh S: Antigen-receptor signaling to nuclear factor kappa B. Immunity. 25:701–715. 2006. View Article : Google Scholar

Bubici C, Papa S, Dean K and Franzoso G: Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene. 25:6731–6748. 2006. View Article : Google Scholar : PubMed/NCBI

Cristobal I, Garcia-Orti L, Cirauqui C, Alonso MM, Calasanz MJ and Odero MD: PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect. Leukemia. 25:606–614. 2011. View Article : Google Scholar : PubMed/NCBI

Yang Y, Huang Q, Lu Y, Li X and Huang S: Reactivating PP2A by FTY720 as a novel therapy for AML with C-KIT tyrosine kinase domain mutation. J Cell Biochem. 113:1314–1322. 2012. View Article : Google Scholar : PubMed/NCBI